Aimmune Therapeutics, Inc. Insider Trading for August 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aimmune Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Aimmune Therapeutics, Inc. for August 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 26 2015 | AIMT | Aimmune Therapeuti ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 19.65 | 25,485 | 500,900 | 355,020 | 329.5 K to 355 K (+7.73 %) |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Longitude Capital Partners II, ... | 10% Owner | Option Exercise | C | 0.00 | 3,248,600 | 0 | 0 | |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Longitude Capital Partners II, ... | 10% Owner | Option Exercise | C | 0.00 | 3,873,530 | 0 | 0 | |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Longitude Capital Partners II, ... | 10% Owner | Buy | P | 16.00 | 312,500 | 5,000,000 | 7,434,630 | 7.1 M to 7.4 M (+4.39 %) |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Longitude Capital Partners II, ... | 10% Owner | Buy | C | 0.00 | 3,248,600 | 0 | 7,122,130 | 3.9 M to 7.1 M (+83.87 %) |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Longitude Capital Partners II, ... | 10% Owner | Buy | C | 0.00 | 3,873,530 | 0 | 3,873,530 | 0 to 3.9 M |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Foresite Capital Management II ... | 10% Owner | Option Exercise | C | 0.00 | 3,775,400 | 0 | 0 | |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 20.50 | 17,035 | 349,199 | 329,535 | 312.5 K to 329.5 K (+5.45 %) |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 16.00 | 312,500 | 5,000,000 | 312,500 | 0 to 312.5 K |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 16.00 | 312,500 | 5,000,000 | 4,087,900 | 3.8 M to 4.1 M (+8.28 %) |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Foresite Capital Management II ... | 10% Owner | Buy | C | 0.00 | 3,775,400 | 0 | 3,775,400 | 0 to 3.8 M |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Iwicki Mark T | Director | Buy | P | 16.00 | 20,000 | 320,000 | 20,000 | 0 to 20 K |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | MCDADE MARK | Director | Buy | P | 16.00 | 16,660 | 266,560 | 16,660 | 0 to 16.7 K |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | FALBERG KATHRYN E | Director | Buy | P | 16.00 | 25,000 | 400,000 | 94,894 | 69.9 K to 94.9 K (+35.77 %) |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | C | 0.00 | 3,248,600 | 0 | 0 | |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | C | 0.00 | 3,873,530 | 0 | 0 | |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | P | 16.00 | 312,500 | 5,000,000 | 7,434,630 | 7.1 M to 7.4 M (+4.39 %) |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | C | 0.00 | 3,248,600 | 0 | 7,122,130 | 3.9 M to 7.1 M (+83.87 %) |
| Aug 11 2015 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | C | 0.00 | 3,873,530 | 0 | 3,873,530 | 0 to 3.9 M |